David Michael Williams is EVP,Chief Info&Digital Officer of Merck & Co., Inc.. Currently has a direct ownership of 19,811 shares of MRK, which is worth approximately $2.25 Million. The most recent transaction as insider was on Feb 07, 2024, when has been sold 1,451 shares (Common Stock) at a price of $127.57 per share, resulting in proceeds of $185,104. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.8K
0% 3M change
79.16% 12M change
Total Value Held $2.25 Million

David Michael Williams Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
SELL
Open market or private sale
$185,104 $127.57 p/Share
1,451 Reduced 6.82%
19,811 Common Stock
Jan 22 2024
BUY
Grant, award, or other acquisition
$1,217,708 $119.43 p/Share
10,196 Added 32.41%
21,262 Common Stock
May 02 2023
SELL
Open market or private sale
$877,201 $116.82 p/Share
7,509 Reduced 40.44%
11,058 Common Stock
May 02 2023
BUY
Exercise of conversion of derivative security
$338,201 $56.04 p/Share
6,035 Added 24.53%
18,567 Common Stock
May 01 2023
SELL
Payment of exercise price or tax liability
$22,863 $115.47 p/Share
198 Reduced 1.56%
12,532 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$66,626 $115.47 p/Share
577 Added 4.34%
12,730 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$44,075 $106.72 p/Share
413 Reduced 3.3%
12,091 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
$128,597 $106.72 p/Share
1,205 Added 8.79%
12,504 Common Stock
Jan 23 2023
BUY
Grant, award, or other acquisition
$191,740 $109.88 p/Share
1,745 Added 13.68%
11,007 Common Stock
May 03 2022
SELL
Payment of exercise price or tax liability
$12,885 $87.65 p/Share
147 Reduced 1.56%
9,262 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
$37,427 $87.65 p/Share
427 Added 4.34%
9,409 Common Stock
May 01 2022
SELL
Payment of exercise price or tax liability
$17,561 $88.69 p/Share
198 Reduced 2.16%
8,982 Common Stock
May 01 2022
BUY
Exercise of conversion of derivative security
$51,174 $88.69 p/Share
577 Added 5.91%
9,180 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
$122,027 $73.51 p/Share
1,660 Added 16.17%
8,603 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$36,505 $76.53 p/Share
477 Reduced 6.43%
6,943 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
$91,989 $76.53 p/Share
1,202 Added 13.94%
7,420 Common Stock
May 04 2021
SELL
Payment of exercise price or tax liability
$10,865 $75.98 p/Share
143 Reduced 2.53%
5,518 Common Stock
May 04 2021
BUY
Exercise of conversion of derivative security
$31,684 $75.98 p/Share
417 Added 6.86%
5,661 Common Stock
May 03 2021
SELL
Payment of exercise price or tax liability
$10,579 $74.5 p/Share
142 Reduced 2.64%
5,244 Common Stock
May 03 2021
BUY
Exercise of conversion of derivative security
$30,694 $74.5 p/Share
412 Added 7.11%
5,386 Common Stock
May 01 2021
SELL
Payment of exercise price or tax liability
$14,304 $74.5 p/Share
192 Reduced 3.72%
4,974 Common Stock
May 01 2021
BUY
Exercise of conversion of derivative security
$41,720 $74.5 p/Share
560 Added 9.78%
5,166 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$151,776 $72.62 p/Share
2,090 Added 31.32%
4,582 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$35,044 $75.04 p/Share
467 Reduced 12.76%
3,192 Common Stock
Feb 10 2021
BUY
Exercise of conversion of derivative security
$87,572 $75.04 p/Share
1,167 Added 24.18%
3,659 Common Stock
DMW

David Michael Williams

EVP,Chief Info&Digital Officer
Kenilworth, NJ

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Track Activities on MRK